ReviewOpen access rheumatology : research and reviews2009
Recent advances in neutralizing the IL-6 pathway in arthritis.
Review in Open access rheumatology : research and reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Epigenomic landscapes define differential Janus kinases inhibitor sensitivity in IFN-γ-primed human macrophages.iScience · 2025Article
- A Synthetic Cell-Penetrating Heparin-Binding Peptide Derived from BMP4 with Anti-Inflammatory and Chondrogenic Functions for the Treatment of Arthritis.International journal of molecular sciences · 2020Article
- Anti-arthritic activity of ferulic acid in complete Freund's adjuvant (CFA)-induced arthritis in rats: JAK2 inhibition.Inflammopharmacology · 2020Article
- Inhibition of MMPs and ADAM/ADAMTS.Biochemical pharmacology · 2019Review
- The role of the JAK/STAT signal pathway in rheumatoid arthritis.Therapeutic advances in musculoskeletal disease · 2018Review
- Phosphorylation of STAT proteins by recombinant human IL-6 in immortalized human chondrocyte cell lines, T/C28a2 and C28/I2.Journal of inflammation research · 2017Article
- STAT1 is Constitutively Activated in the T/C28a2 Immortalized Juvenile Human Chondrocyte Line and Stimulated by IL-6 Plus Soluble IL-6R.Journal of clinical & cellular immunology · 2015Article
- Design and optimisation of bioactive cyclic peptides: generation of a down-regulator of TNF secretion.Molecules (Basel, Switzerland) · 2014Article
- Intracellular Signaling Pathways in Rheumatoid Arthritis.Journal of clinical & cellular immunology · 2013Article
- Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity.Therapeutic advances in chronic disease · 2012Article
- Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway.Pharmaceuticals (Basel, Switzerland) · 2010Review
- Association of periodontitis with rheumatoid arthritis and atherosclerosis: Novel paradigms in etiopathogeneses and management?Open access rheumatology : research and reviews · 2010Review
- The discovery of novel experimental therapies for inflammatory arthritis.Mediators of inflammation · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent advances in understanding the mechanism(s) of how IL-6
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.